Harold Andre Aubrey de Lavenu - 31 Dec 2017 Form 5/A - Amendment Insider Report for CEN BIOTECH INC

Role: Director
Signature: /s/ Harold Aubrey de Lavenu
Issuer symbol: N/A
Transactions as of: 31 Dec 2017
Net transactions value: $0
Form type: 5/A - Amendment
Filing time: 28 May 2021, 08:31:35 UTC
Date Of Original Report: 26 Apr 2021
Previous filing: 28 May 2021
Next filing: 28 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CENBF	Common Stock	Award	$0	+20,000	+3%	$0.000000	689,571	30 Nov 2017	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	20,000 shares of common stock of issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
F2	689,571 shares were beneficially owned by the reporting person of which 656,250 shares were issuable upon conversion of convertible notes held by the reporting person at 12/31/2017.

Remarks:

The reporting person has served as a member of the board of directors of the issuer since July 2017 and was appointed to serve as a vice president of the issuer on April 2, 2021.